Abstract
Ninety strains of Salmonella and 50 strains of Shigella were tested for susceptibility to fosfomycin, chloramphenicol, and ampicillin by the agar dilution method. Drug interaction between fosfomycin-ampicillin and fosfomycin-chloramphenicol was studied by the agar dilution method. The fractional inhibitory concentration was calculated. The combination of fosfomycin-ampicillin was synergistic against Salmonella in 74 cases, additive in 7, indifferent in 7, antagonistic in none, and nonevaluable in 2; against Shigella it was synergistic in 27 cases, additive in 9, indifferent in 14, and antagonistic in none. The combination of fosfomycin-chloramphenicol was synergistic against Salmonella in 56 cases, additive in 9, indifferent in 13, nonevaluable in 12, and antagonistic in none; against Shigella it was synergistic in 29 cases, additive in 10, indifferent in 9, nonevaluable in 2, and antagonistic in none. Killing curves with combinations of each antimicrobial agent showed that the cultures that had proven to be indifferent by the agar dilution method showed a bactericidal effect until h 4, with posterior regrowth of the culture after this time period. For the strains in which synergism was demonstrated, total bactericidal activity was reached at 24 h.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BULGER R. J., KIRBY W. M. GENTAMICIN AND AMPICILLIN: SYNERGISM WITH OTHER ANTIBIOTICS. Am J Med Sci. 1963 Dec;246:717–726. doi: 10.1097/00000441-196312000-00013. [DOI] [PubMed] [Google Scholar]
- Daschner F. D. [Combination of bacteriostatic and bactericidal drugs: lack of significant in vitro antagonism between penicillin, cephalothin, and rolitetracycline]. Antimicrob Agents Chemother. 1976 Nov;10(5):802–808. doi: 10.1128/aac.10.5.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ELION G. B., SINGER S., HITCHINGS G. H. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J Biol Chem. 1954 Jun;208(2):477–488. [PubMed] [Google Scholar]
- Kahan F. M., Kahan J. S., Cassidy P. J., Kropp H. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci. 1974 May 10;235(0):364–386. doi: 10.1111/j.1749-6632.1974.tb43277.x. [DOI] [PubMed] [Google Scholar]
- Libke R. D., Regamey C., Clarke J. T., Kirby W. M. Synergism of carbenicillin and gentamicin against enterococci. Antimicrob Agents Chemother. 1973 Nov;4(5):564–568. doi: 10.1128/aac.4.5.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moreno-López M., Dámaso D., Perea E. J., Sousa A. S., Martínez L., Marco L. Phosphonomycin (MK-955). Quantitative sensitivity spectra of various hospital strains to this new antibiotic. Microbiol Esp. 1971 Apr-Jun;24(2):79–85. [PubMed] [Google Scholar]
- Phillips I., Warren C. Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis. Antimicrob Agents Chemother. 1976 May;9(5):736–740. doi: 10.1128/aac.9.5.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenblatt J. E., Stewart P. R. Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli. Antimicrob Agents Chemother. 1974 Jul;6(1):84–92. doi: 10.1128/aac.6.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
